Maria Libera Ascierto

Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce

Harriet M. Kluger, Hussein A. Tawbi, Maria Libera Ascierto et al. · Journal for ImmunoTherapy of Cancer · 2020 · 260 citations · Full text

New Agents, Immunology, Immunoediting +17

The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti–PD-1 Response in Patients with Renal Cell Carcinoma

Maria Libera Ascierto, Tracee L. McMiller, Alan E. Berger et al. · Cancer Immunology Research · 2016 · 238 citations · Full text

Immunology, Tumor Biology, Genitourinary Cancer +18

A signature of immune function genes associated with recurrence-free survival in breast cancer patients

Maria Libera Ascierto, Maciej Kmieciak, Michael O. Idowu et al. · Breast Cancer Research and Treatment · 2011 · 171 citations · Full text

Breast Oncology, Cancer Immunosurveillance, Breast Cancer Patients +9

Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma

Qian Xie, Robert H. Bradley, Liang Kang et al. · Proceedings of the National Academy of Sciences · 2011 · 125 citations · Full text

Glioma, Tumor Biology, Neuro-oncology +17

Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients

Maria Libera Ascierto, Michael O. Idowu, Yingdong Zhao et al. · Journal of Translational Medicine · 2013 · 103 citations · Full text